iGMDRD117
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Docetaxel | CHEMBL92 CHEMBL3545252 | 148124 | D07866 | DB01248 | Alone | DAP000590 | Small Molecule |
Drug Class:
Antimitotic AgentsAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsCardiotoxic antineoplastic agentsCyclodecanesCycloparaffinsCytochrome P-450 Enzyme InhibitorsDiterpenesHydrocarbonsHydrocarbons, AlicyclicHydrocarbons, CyclicImmunosuppressive AgentsMacrocyclic CompoundsMicrotubule InhibitorsMitosis ModulatorsMyelosuppressive AgentsP-glycoprotein/ABCB1 SubstratesPolycyclic CompoundsTaxane DerivativesTaxoidsTerpenesTubulin ModulatorsDrug Targets:
MicrotubulesTUBB1 (Q9H4B7)BCL2 (P10415)MAP2 (P11137)MAP4 (P27816)MAPT (P10636)NR1I2 (O75469)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene ID | Gene Name | Model Num. |
---|---|---|
7514 | XPO1 | 1 |
9077 | DIRAS3 | 1 |
2956 | MSH6 | 1 |
3845 | KRAS | 6 |
8289 | ARID1A | 1 |
64783 | RBM15 | 1 |
5159 | PDGFRB | 1 |
4851 | NOTCH1 | 1 |
7852 | CXCR4 | 1 |
25937 | WWTR1 | 1 |
2064 | ERBB2 | 2 |
6850 | SYK | 1 |
10413 | YAP1 | 1 |
1029 | CDKN2A | 1 |
7157 | TP53 | 2 |
3673 | ITGA2 | 1 |
6714 | SRC | 1 |
6794 | STK11 | 4 |
3791 | KDR | 1 |
4086 | SMAD1 | 1 |
3481 | IGF2 | 1 |
6934 | TCF7L2 | 1 |
4089 | SMAD4 | 2 |
672 | BRCA1 | 1 |
1978 | EIF4EBP1 | 1 |
1956 | EGFR | 4 |
54206 | ERRFI1 | 1 |
7515 | XRCC1 | 1 |
673 | BRAF | 1 |
613253 | DEFA1A3 | 1 |
3485 | IGFBP2 | 1 |
7301 | TYRO3 | 1 |
1938 | EEF2 | 1 |
84617 | TUBB6 | 1 |
5728 | PTEN | 2 |
1869 | E2F1 | 1 |
3429 | IFI27 | 1 |
2067 | ERCC1 | 1 |
100862685 | ERVK-19 | 1 |
5054 | SERPINE1 | 1 |
4893 | NRAS | 1 |
2065 | ERBB3 | 1 |
1857 | DVL3 | 1 |
374 | AREG | 1 |
595 | CCND1 | 1 |
94 | ACVRL1 | 1 |
2621 | GAS6 | 1 |
1803 | DPP4 | 2 |
5624 | PROC | 1 |
Gene in drug-gene network: Network Plot
Models in Docetaxel